THOR Photomedicine Ltd

THOR Photomedicine Ltd is an ISO 13485:2016-certified medical device manufacturer based in Amersham, England, specializing in photobiomodulation (PBM) therapy equipment—also known as low-level laser therapy (LLLT). Founded in 2007, the company designs and manufactures advanced laser and LED light therapy systems, treatment probes, and control units for clinical and therapeutic applications. THOR serves over 5,000 customers across more than 70 countries, including hospitals, clinics, sports franchises, and veterinary practices. The company holds FDA, CE, TGA, and NATO clearance and is listed on the US GSA and eCAT schedules for government procurement. THOR's flagship product, the LX2.3 Photobiomodulation System, delivers targeted light therapy for pain relief, tissue repair, and inflammation reduction across indications including musculoskeletal pain, oral mucositis, tendinopathies, joint conditions, wound healing, and sports medicine. The company is backed by extensive clinical research partnerships with leading universities and has supported over 1,700 randomized controlled trials and 11,000+ publications. THOR provides comprehensive training courses globally and maintains a commitment to establishing photobiomodulation as standard care in hospital departments by 2030.